BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20682295)

  • 1. Suppressed phosphorylation of collapsin response mediator protein-2 in the hippocampus of HCNP precursor transgenic mice.
    Kanamori T; Matsukawa N; Kobayashi H; Uematsu N; Sagisaka T; Toyoda T; Kato D; Oikawa S; Ojika K
    Brain Res; 2010 Oct; 1355():180-8. PubMed ID: 20682295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCNP precursor protein transgenic mice display a depressive-like phenotype in old age.
    Matsukawa N; Furuya Y; Ogura H; Ojika K
    Brain Res; 2010 Aug; 1349():153-61. PubMed ID: 20599825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of collapsin response mediator protein-2 regulates its localization and association with hippocampal cholinergic neurostimulating peptide precursor in the hippocampus.
    Mizuno M; Kato D; Kanamori T; Toyoda T; Suzuki T; Ojika K; Matsukawa N
    Neurosci Lett; 2013 Feb; 535():122-7. PubMed ID: 23276635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-localization of hippocampal cholinergic neurostimulating peptide precursor with collapsin response mediator protein-2 at presynaptic terminals in hippocampus.
    Kato D; Mitake S; Mizuno M; Kanamori T; Suzuki T; Ojika K; Matsukawa N
    Neurosci Lett; 2012 May; 517(2):92-7. PubMed ID: 22542739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus.
    Uematsu N; Matsukawa N; Kanamori T; Arai Y; Sagisaka T; Toyoda T; Yoshida M; Ojika K
    Brain Res; 2009 Dec; 1305():150-7. PubMed ID: 19815004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Function of HCNP/HCNP precursor in memory formation].
    Matsukawa N; Ojika K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):219-27. PubMed ID: 17240848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of long-term potentiation via muscarinic modulation in the hippocampus of HCNP precursor transgenic mice.
    Ohi Y; Kato D; Mizuno M; Sato T; Ueki Y; Borlongan CV; Ojika K; Haji A; Matsukawa N
    Neurosci Lett; 2015 Jun; 597():1-6. PubMed ID: 25899776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of HCNP-related antigens in hippocampus in senescence-accelerated mice.
    Yamada K; Matsukawa N; Yuasa H; Hattori M; Nakazawa H; Borlongan CV; Ojika K
    Brain Res; 2007 Jul; 1158():169-75. PubMed ID: 17570350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The involvement of hippocampal cholinergic neurostimulating peptide and its precursor in Alzheimer pathogenesis].
    Matsukawa N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2014 Jun; 34(3):93-100. PubMed ID: 25076779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed neural lineage differentiation of adult hippocampal progenitor cells via modulation of hippocampal cholinergic neurostimulating peptide precursor expression.
    Sagisaka T; Matsukawa N; Toyoda T; Uematsu N; Kanamori T; Wake H; Borlongan CV; Ojika K
    Brain Res; 2010 Apr; 1327():107-17. PubMed ID: 20206149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Cholinergic Activity in the Hippocampus of Hippocampal Cholinergic Neurostimulating Peptide Precursor Protein Knockout Mice.
    Madokoro Y; Yoshino Y; Kato D; Sato T; Mizuno M; Kanamori T; Shimazawa M; Hida H; Hara H; Yoshida M; Borlongan CV; Ojika K; Matsukawa N
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased hippocampal cholinergic neurostimulating peptide precursor protein associated with stress exposure in rat brain by proteomic analysis.
    Kim HG; Kim KL
    J Neurosci Res; 2007 Oct; 85(13):2898-908. PubMed ID: 17628502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of acetylcholine in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice.
    Kondo-Takuma Y; Mizuno M; Tsuda Y; Madokoro Y; Suzuki K; Sato T; Takase H; Uchida Y; Adachi KI; Hida H; Borlongan CV; Matsukawa N
    Sci Rep; 2021 Nov; 11(1):22072. PubMed ID: 34764402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal.
    Wei QH; Wu N; Bian JM; Chen Y; Su RB; Li J
    Addict Biol; 2013 Mar; 18(2):230-40. PubMed ID: 21967037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease.
    George AJ; Holsinger RM; McLean CA; Tan SS; Scott HS; Cardamone T; Cappai R; Masters CL; Li QX
    Neurobiol Aging; 2006 Apr; 27(4):614-23. PubMed ID: 15941609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal Cholinergic Neurostimulating Peptide Suppresses Acetylcholine Synthesis in T Lymphocytes.
    Saito Y; Mashimo M; Nobeyama A; Murakami K; Fujii T
    Biol Pharm Bull; 2018; 41(10):1611-1614. PubMed ID: 30270332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles.
    Matsukawa N; Ikenaka K; Nanmoku K; Yuasa H; Hattori M; Kawano M; Nakazawa H; Fujimori O; Ueda R; Ojika K
    Dev Neurosci; 2003; 25(5):349-56. PubMed ID: 14614262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Enhancement Effect of Hippocampal Cholinergic Neurostimulating Peptide on Cholinergic Activity in the Hippocampus.
    Madokoro Y; Kato D; Tsuda Y; Arakawa I; Suzuki K; Sato T; Mizuno M; Uchida Y; Ojika K; Matsukawa N
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of astrocyte lineage in adult hippocampal progenitor cells expressing hippocampal cholinergic neurostimulating Peptide precursor in an in vivo ischemic model.
    Toyoda T; Matsukawa N; Sagisaka T; Uematsu N; Kanamori T; Kato D; Mizuno M; Wake H; Hida H; Borlongan CV; Ojika K
    Cell Transplant; 2012; 21(10):2159-69. PubMed ID: 22469272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease.
    Maki M; Matsukawa N; Yuasa H; Otsuka Y; Yamamoto T; Akatsu H; Okamoto T; Ueda R; Ojika K
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):176-85. PubMed ID: 11853019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.